Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ·Healthcare·Biotechnology
$30.91
-6.35%
Mkt Cap $3.63B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (19 analysts)
$32.67
Range $24.00 – $40.00
Implied Upside
+5.7%
Consensus $32.67 vs current $30.91
NASDAQ·Healthcare·Biotechnology
$30.91
-6.35%
Mkt Cap $3.63B
Buy
10
Hold
0
Sell
0
Price Target (19 analysts)
$32.67
Range $24.00 – $40.00
+5.7%
Consensus $32.67 vs current $30.91